Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00187876 · ClinicalTrials.gov registry record · Phase 4
Evaluation of Biocleanse Allografts For ACL Reconstruction
A Phase 4 study, sponsored by University of Florida.
- Completed
- Registry status
- Phase 4
- Development phase
- 67
- Enrollment target
NCT00187876: Completed Phase 4 study, sponsored by University of Florida.
NCT00187876 is a Phase 4 study that has completed, run by University of Florida. The registered enrollment target is 67 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (87% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00187876, a Phase 4 study, has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 67 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the efficacy of patellar tendon allografts that have undergone the BioCleanse™ process.
Primary Outcome
The IKDC Subjective Evaluation Form is scored by summing the scores for the individual items and then transforming the score to a scale that ranges from 0-100. A score of 100 is interpreted to mean no limitation with activities of daily living and the absence of symptoms.
Interventions
- PROCEDURE ACL reconstruction control
- PROCEDURE ACL Biocleanse, surgical
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 67 participants |
| Start Date | 2004-02 |
| Est. Completion | 2012-12 |
| Phase | Phase 4 |
What the finished NCT00187876 record still lists
NCT00187876 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 67 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (87% lower).
The record links to 0 conditions, and to 2 interventions - of which ACL reconstruction control is the first listed.
NCT00187876 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00187876 about?
NCT00187876 is a clinical study titled "Evaluation of Biocleanse Allografts For ACL Reconstruction". The purpose of this study is to determine the efficacy of patellar tendon allografts that have undergone the BioCleanse™ process.
What is the current status of trial NCT00187876?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 67 participants. The study started on 2004-02. Estimated completion is 2012-12.
What interventions are being tested in trial NCT00187876?
The interventions under investigation include: ACL reconstruction control (PROCEDURE), ACL Biocleanse, surgical (PROCEDURE).
Who is sponsoring clinical trial NCT00187876?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00187876's enrollment target sits among peer trials
67 1083rd of 2000 higher than 918 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03213002 · 67 participants · Phase 1
Oral Capecitabine and Temozolomide (CAPTEM) for Newly Diagnosed GBM
- NCT04115163 · 67 participants · Phase 2
Biologically Optimized Infusion Schedule of Gemcitabine and Nab-Paclitaxel for the Treatment of Metastatic Pancreatic Cancer
- NCT04315324 · 67 participants · Phase 1
Study to Test OBI-3424 in Patients With T-Cell Acute Lymphoblastic Leukemia (T-ALL) or T-Cell Lymphoblastic Lymphoma (T-LBL)
- NCT04532424 · 67 participants · NA
Transcranial Magnetic Stimulation for Restricted and Repetitive Behavior in ASD
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia